Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Clinical trial NCT00837876 · COMPLETED
Trial details
- NCT number
- NCT00837876
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-04-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.